Clinical usefulness of conversion surgery for unresectable pancreatic cancer diagnosed on multidetector computed tomography imaging: Results from a multicenter observational cohort study by the Hokkaido Pancreatic Cancer Study Group (HOPS UR‐01)

Abstract Background and Aim Effective multidisciplinary approaches for unresectable pancreatic cancer (UR‐PC) that include modern chemotherapeutic regimens and subsequent conversion surgery (CS) are being developed. The aim of this study was to evaluate outcomes of patients clinically diagnosed with...

Full description

Bibliographic Details
Main Authors: Yasutoshi Kimura, Toru Nakamura, Tsuyoshi Hayashi, Masaki Kuwatani, Masayo Motoya, Makoto Yoshida, Masafumi Imamura, Minoru Nagayama, Hiroshi Yamaguchi, Keisuke Yamakita, Takuma Goto, Yusuke Sakuhara, Kuniyuki Takahashi, Hiroyuki Maguchi, Satoshi Hirano, Ichiro Takemasa
Format: Article
Language:English
Published: Wiley 2019-09-01
Series:Annals of Gastroenterological Surgery
Subjects:
Online Access:https://doi.org/10.1002/ags3.12272
_version_ 1818616988015001600
author Yasutoshi Kimura
Toru Nakamura
Tsuyoshi Hayashi
Masaki Kuwatani
Masayo Motoya
Makoto Yoshida
Masafumi Imamura
Minoru Nagayama
Hiroshi Yamaguchi
Keisuke Yamakita
Takuma Goto
Yusuke Sakuhara
Kuniyuki Takahashi
Hiroyuki Maguchi
Satoshi Hirano
Ichiro Takemasa
author_facet Yasutoshi Kimura
Toru Nakamura
Tsuyoshi Hayashi
Masaki Kuwatani
Masayo Motoya
Makoto Yoshida
Masafumi Imamura
Minoru Nagayama
Hiroshi Yamaguchi
Keisuke Yamakita
Takuma Goto
Yusuke Sakuhara
Kuniyuki Takahashi
Hiroyuki Maguchi
Satoshi Hirano
Ichiro Takemasa
author_sort Yasutoshi Kimura
collection DOAJ
description Abstract Background and Aim Effective multidisciplinary approaches for unresectable pancreatic cancer (UR‐PC) that include modern chemotherapeutic regimens and subsequent conversion surgery (CS) are being developed. The aim of this study was to evaluate outcomes of patients clinically diagnosed with UR‐PC, focusing on the efficacy of CS. Methods Patients ineligible for two multicenter phase II studies conducted by the Hokkaido Pancreatic Cancer Study Group (HOPS) were recruited. Sequential treatment regimens, conversion to radical surgery, and overall survival (OS) were analyzed by multidetector computed tomography (MDCT)‐based UR factors. Univariate and multivariate analyses were performed to identify predictors of OS. Results Sixty‐six of 247 intended recruits for HOPS studies from October 2013 to April 2016 were included. Unresectability was due to locally advanced (LA) disease and metastasis (M) in 42 and 24 patients, respectively. Induction therapy began with chemotherapy (CT) and chemoradiotherapy (CRT) in 44 and 17 patients, respectively, of whom 23 received modern CT regimens. Radical surgery was completed in 12 (LA, 10; M, two) with a median treatment interval of 10.3 months (range, 2‐32). Eleven patients (91.6%) achieved pathological R0 resection. Median OS was significantly longer in patients who underwent CS than those who did not (44.1 vs 14.5 months, P < 0.0001). CS was an independent predictor of OS (hazard ratio, 0.078; 95% confident interval, 0.017‐0.348; P = 0.001). Conclusion Conversion surgery after a favorable response to sequential treatment might prolong survival in patients with UR‐PC. Precise diagnosis on MDCT followed by sequential multimodal anticancer treatment is essential.
first_indexed 2024-12-16T16:58:32Z
format Article
id doaj.art-22208a636cd54d64861323ddb6ea2be9
institution Directory Open Access Journal
issn 2475-0328
language English
last_indexed 2024-12-16T16:58:32Z
publishDate 2019-09-01
publisher Wiley
record_format Article
series Annals of Gastroenterological Surgery
spelling doaj.art-22208a636cd54d64861323ddb6ea2be92022-12-21T22:23:49ZengWileyAnnals of Gastroenterological Surgery2475-03282019-09-013552353310.1002/ags3.12272Clinical usefulness of conversion surgery for unresectable pancreatic cancer diagnosed on multidetector computed tomography imaging: Results from a multicenter observational cohort study by the Hokkaido Pancreatic Cancer Study Group (HOPS UR‐01)Yasutoshi Kimura0Toru Nakamura1Tsuyoshi Hayashi2Masaki Kuwatani3Masayo Motoya4Makoto Yoshida5Masafumi Imamura6Minoru Nagayama7Hiroshi Yamaguchi8Keisuke Yamakita9Takuma Goto10Yusuke Sakuhara11Kuniyuki Takahashi12Hiroyuki Maguchi13Satoshi Hirano14Ichiro Takemasa15Department of Surgery Surgical Oncology and Science Sapporo Medical University School of Medicine Sapporo JapanHokkaido Pancreatic Cancer Study Group; HOPS Sapporo JapanHokkaido Pancreatic Cancer Study Group; HOPS Sapporo JapanHokkaido Pancreatic Cancer Study Group; HOPS Sapporo JapanHokkaido Pancreatic Cancer Study Group; HOPS Sapporo JapanHokkaido Pancreatic Cancer Study Group; HOPS Sapporo JapanDepartment of Surgery Surgical Oncology and Science Sapporo Medical University School of Medicine Sapporo JapanDepartment of Surgery Surgical Oncology and Science Sapporo Medical University School of Medicine Sapporo JapanDepartment of Surgery Surgical Oncology and Science Sapporo Medical University School of Medicine Sapporo JapanHokkaido Pancreatic Cancer Study Group; HOPS Sapporo JapanHokkaido Pancreatic Cancer Study Group; HOPS Sapporo JapanHokkaido Pancreatic Cancer Study Group; HOPS Sapporo JapanHokkaido Pancreatic Cancer Study Group; HOPS Sapporo JapanHokkaido Pancreatic Cancer Study Group; HOPS Sapporo JapanHokkaido Pancreatic Cancer Study Group; HOPS Sapporo JapanDepartment of Surgery Surgical Oncology and Science Sapporo Medical University School of Medicine Sapporo JapanAbstract Background and Aim Effective multidisciplinary approaches for unresectable pancreatic cancer (UR‐PC) that include modern chemotherapeutic regimens and subsequent conversion surgery (CS) are being developed. The aim of this study was to evaluate outcomes of patients clinically diagnosed with UR‐PC, focusing on the efficacy of CS. Methods Patients ineligible for two multicenter phase II studies conducted by the Hokkaido Pancreatic Cancer Study Group (HOPS) were recruited. Sequential treatment regimens, conversion to radical surgery, and overall survival (OS) were analyzed by multidetector computed tomography (MDCT)‐based UR factors. Univariate and multivariate analyses were performed to identify predictors of OS. Results Sixty‐six of 247 intended recruits for HOPS studies from October 2013 to April 2016 were included. Unresectability was due to locally advanced (LA) disease and metastasis (M) in 42 and 24 patients, respectively. Induction therapy began with chemotherapy (CT) and chemoradiotherapy (CRT) in 44 and 17 patients, respectively, of whom 23 received modern CT regimens. Radical surgery was completed in 12 (LA, 10; M, two) with a median treatment interval of 10.3 months (range, 2‐32). Eleven patients (91.6%) achieved pathological R0 resection. Median OS was significantly longer in patients who underwent CS than those who did not (44.1 vs 14.5 months, P < 0.0001). CS was an independent predictor of OS (hazard ratio, 0.078; 95% confident interval, 0.017‐0.348; P = 0.001). Conclusion Conversion surgery after a favorable response to sequential treatment might prolong survival in patients with UR‐PC. Precise diagnosis on MDCT followed by sequential multimodal anticancer treatment is essential.https://doi.org/10.1002/ags3.12272locally advancedmetastaticmultidisciplinary treatmentradical surgeryunresectable pancreatic cancer
spellingShingle Yasutoshi Kimura
Toru Nakamura
Tsuyoshi Hayashi
Masaki Kuwatani
Masayo Motoya
Makoto Yoshida
Masafumi Imamura
Minoru Nagayama
Hiroshi Yamaguchi
Keisuke Yamakita
Takuma Goto
Yusuke Sakuhara
Kuniyuki Takahashi
Hiroyuki Maguchi
Satoshi Hirano
Ichiro Takemasa
Clinical usefulness of conversion surgery for unresectable pancreatic cancer diagnosed on multidetector computed tomography imaging: Results from a multicenter observational cohort study by the Hokkaido Pancreatic Cancer Study Group (HOPS UR‐01)
Annals of Gastroenterological Surgery
locally advanced
metastatic
multidisciplinary treatment
radical surgery
unresectable pancreatic cancer
title Clinical usefulness of conversion surgery for unresectable pancreatic cancer diagnosed on multidetector computed tomography imaging: Results from a multicenter observational cohort study by the Hokkaido Pancreatic Cancer Study Group (HOPS UR‐01)
title_full Clinical usefulness of conversion surgery for unresectable pancreatic cancer diagnosed on multidetector computed tomography imaging: Results from a multicenter observational cohort study by the Hokkaido Pancreatic Cancer Study Group (HOPS UR‐01)
title_fullStr Clinical usefulness of conversion surgery for unresectable pancreatic cancer diagnosed on multidetector computed tomography imaging: Results from a multicenter observational cohort study by the Hokkaido Pancreatic Cancer Study Group (HOPS UR‐01)
title_full_unstemmed Clinical usefulness of conversion surgery for unresectable pancreatic cancer diagnosed on multidetector computed tomography imaging: Results from a multicenter observational cohort study by the Hokkaido Pancreatic Cancer Study Group (HOPS UR‐01)
title_short Clinical usefulness of conversion surgery for unresectable pancreatic cancer diagnosed on multidetector computed tomography imaging: Results from a multicenter observational cohort study by the Hokkaido Pancreatic Cancer Study Group (HOPS UR‐01)
title_sort clinical usefulness of conversion surgery for unresectable pancreatic cancer diagnosed on multidetector computed tomography imaging results from a multicenter observational cohort study by the hokkaido pancreatic cancer study group hops ur 01
topic locally advanced
metastatic
multidisciplinary treatment
radical surgery
unresectable pancreatic cancer
url https://doi.org/10.1002/ags3.12272
work_keys_str_mv AT yasutoshikimura clinicalusefulnessofconversionsurgeryforunresectablepancreaticcancerdiagnosedonmultidetectorcomputedtomographyimagingresultsfromamulticenterobservationalcohortstudybythehokkaidopancreaticcancerstudygrouphopsur01
AT torunakamura clinicalusefulnessofconversionsurgeryforunresectablepancreaticcancerdiagnosedonmultidetectorcomputedtomographyimagingresultsfromamulticenterobservationalcohortstudybythehokkaidopancreaticcancerstudygrouphopsur01
AT tsuyoshihayashi clinicalusefulnessofconversionsurgeryforunresectablepancreaticcancerdiagnosedonmultidetectorcomputedtomographyimagingresultsfromamulticenterobservationalcohortstudybythehokkaidopancreaticcancerstudygrouphopsur01
AT masakikuwatani clinicalusefulnessofconversionsurgeryforunresectablepancreaticcancerdiagnosedonmultidetectorcomputedtomographyimagingresultsfromamulticenterobservationalcohortstudybythehokkaidopancreaticcancerstudygrouphopsur01
AT masayomotoya clinicalusefulnessofconversionsurgeryforunresectablepancreaticcancerdiagnosedonmultidetectorcomputedtomographyimagingresultsfromamulticenterobservationalcohortstudybythehokkaidopancreaticcancerstudygrouphopsur01
AT makotoyoshida clinicalusefulnessofconversionsurgeryforunresectablepancreaticcancerdiagnosedonmultidetectorcomputedtomographyimagingresultsfromamulticenterobservationalcohortstudybythehokkaidopancreaticcancerstudygrouphopsur01
AT masafumiimamura clinicalusefulnessofconversionsurgeryforunresectablepancreaticcancerdiagnosedonmultidetectorcomputedtomographyimagingresultsfromamulticenterobservationalcohortstudybythehokkaidopancreaticcancerstudygrouphopsur01
AT minorunagayama clinicalusefulnessofconversionsurgeryforunresectablepancreaticcancerdiagnosedonmultidetectorcomputedtomographyimagingresultsfromamulticenterobservationalcohortstudybythehokkaidopancreaticcancerstudygrouphopsur01
AT hiroshiyamaguchi clinicalusefulnessofconversionsurgeryforunresectablepancreaticcancerdiagnosedonmultidetectorcomputedtomographyimagingresultsfromamulticenterobservationalcohortstudybythehokkaidopancreaticcancerstudygrouphopsur01
AT keisukeyamakita clinicalusefulnessofconversionsurgeryforunresectablepancreaticcancerdiagnosedonmultidetectorcomputedtomographyimagingresultsfromamulticenterobservationalcohortstudybythehokkaidopancreaticcancerstudygrouphopsur01
AT takumagoto clinicalusefulnessofconversionsurgeryforunresectablepancreaticcancerdiagnosedonmultidetectorcomputedtomographyimagingresultsfromamulticenterobservationalcohortstudybythehokkaidopancreaticcancerstudygrouphopsur01
AT yusukesakuhara clinicalusefulnessofconversionsurgeryforunresectablepancreaticcancerdiagnosedonmultidetectorcomputedtomographyimagingresultsfromamulticenterobservationalcohortstudybythehokkaidopancreaticcancerstudygrouphopsur01
AT kuniyukitakahashi clinicalusefulnessofconversionsurgeryforunresectablepancreaticcancerdiagnosedonmultidetectorcomputedtomographyimagingresultsfromamulticenterobservationalcohortstudybythehokkaidopancreaticcancerstudygrouphopsur01
AT hiroyukimaguchi clinicalusefulnessofconversionsurgeryforunresectablepancreaticcancerdiagnosedonmultidetectorcomputedtomographyimagingresultsfromamulticenterobservationalcohortstudybythehokkaidopancreaticcancerstudygrouphopsur01
AT satoshihirano clinicalusefulnessofconversionsurgeryforunresectablepancreaticcancerdiagnosedonmultidetectorcomputedtomographyimagingresultsfromamulticenterobservationalcohortstudybythehokkaidopancreaticcancerstudygrouphopsur01
AT ichirotakemasa clinicalusefulnessofconversionsurgeryforunresectablepancreaticcancerdiagnosedonmultidetectorcomputedtomographyimagingresultsfromamulticenterobservationalcohortstudybythehokkaidopancreaticcancerstudygrouphopsur01